Old Web
English
Sign In
Acemap
>
authorDetail
>
Trevor McMullan
Trevor McMullan
Pfizer
Nilotinib
Immunology
Internal medicine
Bosutinib
Dasatinib
2
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Bosutinib as Third-Line Treatment for Chronic Phase Chronic Myeloid Leukemia Following Failure of Second-Line Therapy with Dasatinib or Nilotinib
2010
Blood
H. Jean Khoury
Dong Wook Kim
Andrey Zaritskey
Carlo Gambacorti Passerini
Andreas Hochhaus
Juan Ramon Navarro
Aaron P. Rapoport
Pedro Enrique Dorlhiac-Llacer
Maria Aparecida Zanichelli
Virginia Kelly
Nadine Besson
Trevor McMullan
Hagop M. Kantarjian
Jorge E. Cortes
Show All
Source
Cite
Save
Citations (2)
Clinical Activity of Bosutinib by Mutational Status In Patients with Previously Treated Philadelphia Chromosome–positive Leukemias.
2010
Blood
Carlo Gambacorti Passerini
H. Jean Khoury
Hélio Pinczowski
Tamas Masszi
Dong Wook Kim
Maria Aparecida Zanichelli
Giovanni Martinelli
Virginia Kelly
Nadine Besson
Trevor McMullan
Tim H. Brümmendorf
Jorge E. Cortes
Show All
Source
Cite
Save
Citations (4)
1